Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients.
Palermo B, Franzese O, Donna CD, Panetta M, Quintarelli C, Sperduti I, Gualtieri N, Foddai ML, Proietti E, Ferraresi V, Ciliberto G, Nisticò P. Palermo B, et al. Among authors: gualtieri n. Oncoimmunology. 2018 Sep 11;7(12):e1465163. doi: 10.1080/2162402X.2018.1465163. eCollection 2018. Oncoimmunology. 2018. PMID: 30524882 Free PMC article.
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients.
Palermo B, Del Bello D, Sottini A, Serana F, Ghidini C, Gualtieri N, Ferraresi V, Catricalà C, Belardelli F, Proietti E, Natali PG, Imberti L, Nisticò P. Palermo B, et al. Among authors: gualtieri n. Cancer Res. 2010 Sep 15;70(18):7084-92. doi: 10.1158/0008-5472.CAN-10-1326. Epub 2010 Sep 7. Cancer Res. 2010. PMID: 20823160
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study.
Urbani F, Ferraresi V, Capone I, Macchia I, Palermo B, Nuzzo C, Torsello A, Pezzotti P, Giannarelli D, Pozzi AF, Santaquilani M, Roazzi P, Bastucci S, Catricalà C, La Malfa A, Vercillo G, Gualtieri N, Buccione C, Castiello L, Cognetti F, Nisticò P, Belardelli F, Moschella F, Proietti E. Urbani F, et al. Among authors: gualtieri n. Front Oncol. 2020 Mar 6;10:202. doi: 10.3389/fonc.2020.00202. eCollection 2020. Front Oncol. 2020. PMID: 32211314 Free PMC article.
Effects of the administration of corticosterone, parathyroid hormone, or both, and of their withdrawal, on rat bone and cartilage histomorphometric parameters, and on osteoprotegerin and RANKL mRNA expression and proteins.
Silvestrini G, Ballanti P, Leopizzi M, Gualtieri N, Sardella D, Monnazzi P, Simeoni S, Sebastiani M, Bonucci E, Patacchioli FR. Silvestrini G, et al. Among authors: gualtieri n. J Mol Histol. 2007 Jun;38(3):215-26. doi: 10.1007/s10735-007-9090-9. Epub 2007 May 3. J Mol Histol. 2007. PMID: 17476578
Acute esophageal necrosis: a rare syndrome.
Gurvits GE, Shapsis A, Lau N, Gualtieri N, Robilotti JG. Gurvits GE, et al. Among authors: gualtieri n. J Gastroenterol. 2007 Jan;42(1):29-38. doi: 10.1007/s00535-006-1974-z. Epub 2007 Feb 16. J Gastroenterol. 2007. PMID: 17322991 Review.
Colorectal carcinoma in young females.
Olofinlade O, Adeonigbagbe O, Gualtieri N, Freiman H, Ogedegbe O, Robilotti J. Olofinlade O, et al. Among authors: gualtieri n. South Med J. 2004 Mar;97(3):231-5. doi: 10.1097/01.SMJ.0000072360.33202.F2. South Med J. 2004. PMID: 15043328
Anal carcinoma: a 15-year retrospective analysis.
Olofinlade O, Adeonigbagbe O, Gualtieri N, Gingold B, Berlin I, Sayeed R, Robilotti J. Olofinlade O, et al. Among authors: gualtieri n. Scand J Gastroenterol. 2000 Nov;35(11):1194-9. doi: 10.1080/003655200750056682. Scand J Gastroenterol. 2000. PMID: 11145292
15 results